How are we advocating for Kidney Cancer?  Find out HERE

In the News

What’s the latest in the news regarding Kidney Cancer? Read below

  • Dr. Hans Hammers, associate professor of internal medicine and co-leader of the Kidney Cancer Program at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. Photo by Ben Torres

This Week: RADVAX at ASCO GU

February 13th, 2020|Comments Off on This Week: RADVAX at ASCO GU

We are so proud to see Dr. Hans Hammers's clinical trial of RADVAX selected for presentation at ASCO GU 2020. ASCO is the American Society of Clinical Oncology, and ASCO GU focuses on genitourinary cancers.

  • FDA Oncology Center of Excellence

A New Era for the FDA: Our Perspective

February 5th, 2020|Comments Off on A New Era for the FDA: Our Perspective

In the past, the work of the Food and Drug Administration was often bogged down by bureaucratic processes and the red tape of a regulatory environment. The drug approval department could be inefficient, and it

  • Gary Cole is surviving kidney cancer thanks to the RADVAX clinical trial.

Clinical Trials Save Lives: Gary’s RADVAX Story

January 24th, 2020|Comments Off on Clinical Trials Save Lives: Gary’s RADVAX Story

January is Clinical Trial Awareness Month. Today, we're featuring a story from Gary Cole, our friend and a kidney cancer patient. He shares his experience with the RADVAX clinical trial, funded by KidneyCAN thanks to

Spring 2020 D.C. Advocacy Days

January 20th, 2020|Comments Off on Spring 2020 D.C. Advocacy Days

In March of 2019, KidneyCAN sponsored the Kidney Cancer Advocacy Day in D.C. This successful event was attended by more than 20 kidney cancer patient advocates from various parts of the country. We had more

Our Communities

Smart Patients is an online community where patients and their families learn from each other. Patients can be extraordinarily knowledgeable about their disease. Get information and support from patients who have expertise to share with you.

Stay in Touch: Join The Kidney Cancer Coalition Email List!

Please enter your information below: